- 130.1k views
Management of Pediatric Pneumonia
Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high healthcare expenses. In this exercise, the multidisciplinary team's crucial role in the treatment of pediatric pneumonia is reviewed along with the cause, pathophysiology, and presentation of the condition.
About the Speaker
Dr.Bharat Parmar
PROFESSOR AND HEAD OF PAEDIATRICS at ZYDUS MEDICAL College, Civil Hospital.
Upcoming Case Discussions
Diabetic Polyneuropathy
Diabetic polyneuropathy is a common complication of diabetes mellitus, characterized by nerve damage throughout the body due to prolonged high blood sugar levels. Symptoms can vary widely, including numbness, tingling, burning pain, weakness, and loss of sensation, typically starting in the feet and gradually spreading to other areas. Diagnosis involves a thorough medical history, neurological examination, and nerve conduction studies. Management focuses on glycemic control through medications, lifestyle modifications, and pain management strategies such as analgesics, anticonvulsants, and antidepressants. Additionally, addressing risk factors such as smoking, hypertension, and dyslipidemia is crucial. Regular monitoring for complications such as foot ulcers and autonomic dysfunction is essential for preventing further nerve damage and improving quality of life.
H. pylori Treatment with PYELRA®: Best Practices
PYLERA® is a medication used for the treatment of Helicobacter pylori (H. pylori) infection, a common cause of stomach ulcers and gastritis. It contains a combination of three active ingredients: bismuth subcitrate potassium, metronidazole, and tetracycline. This combination works synergistically to eradicate H. pylori bacteria and reduce associated symptoms. Treatment with PYLERA® typically involves taking multiple capsules four times a day for a specified duration, as prescribed by a healthcare provider. It is important to follow the treatment regimen as directed and to discuss potential side effects
Management of Pulmonary Fibrosis
Pulmonary fibrosis is diagnosed through a combination of medical history, imaging studies (like high-resolution CT scans), pulmonary function tests, and sometimes lung biopsies. Treatment often involves medications such as corticosteroids, immunosuppressants (like azathioprine or mycophenolate), and antifibrotic drugs (such as pirfenidone or nintedanib) to slow disease progression and manage symptoms.Supplemental oxygen therapy is commonly prescribed to relieve shortness of breath and improve oxygen levels in the blood. This program combines exercise training, education, and breathing techniques to improve overall physical condition and quality of life. Patients with pulmonary fibrosis should receive vaccinations against influenza and pneumococcal pneumonia to reduce the risk of respiratory infections. In severe cases, lung transplantation may be considered for eligible patients to improve survival and quality of life. Treatments like nutritional support, psychological counseling, and palliative care can provide comprehensive support and symptom management.
Alcoholic Hepatitis: Management Strategies
Management of alcoholic hepatitis involves a comprehensive approach aimed at halting disease progression, managing symptoms, and promoting liver recovery. The cornerstone of treatment involves complete alcohol cessation to prevent further liver damage and promote healing. Patients often have malnutrition, so nutritional therapy with a focus on adequate protein intake and vitamin supplementation is crucial. Corticosteroids like prednisolone may be prescribed in severe cases to reduce liver inflammation and improve survival rates. In severe cases unresponsive to medical therapy, liver transplantation may be considered, although strict criteria must be met. Diuretics may be used cautiously to manage ascites while monitoring for renal function. Prophylactic measures such as beta-blockers may be used to reduce the risk of variceal bleeding.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr.Bharat Parmar's Talks on Assimilate
- 17th-November-2022, TIME : 4:00PM - 5:00PM
- 0
Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high healthcare expenses. In this exercise, the multidisciplinary team's crucial role in the treatment of pediatric pneumonia is reviewed along with the cause, pathophysiology, and presentation of the condition.
- 17th-November-2022, TIME : 4:00PM - 5:00PM
- 0
Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high healthcare expenses. In this exercise, the multidisciplinary team's crucial role in the treatment of pediatric pneumonia is reviewed along with the cause, pathophysiology, and presentation of the condition.
- 17th-November-2022, TIME : 4:00PM - 5:00PM
- 0
Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high healthcare expenses. In this exercise, the multidisciplinary team's crucial role in the treatment of pediatric pneumonia is reviewed along with the cause, pathophysiology, and presentation of the condition.
- 17th-November-2022, TIME : 4:00PM - 5:00PM
- 0
Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high healthcare expenses. In this exercise, the multidisciplinary team's crucial role in the treatment of pediatric pneumonia is reviewed along with the cause, pathophysiology, and presentation of the condition.
- 17th-November-2022, TIME : 4:00PM - 5:00PM
- 0
Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high healthcare expenses. In this exercise, the multidisciplinary team's crucial role in the treatment of pediatric pneumonia is reviewed along with the cause, pathophysiology, and presentation of the condition.
- 17th-November-2022, TIME : 4:00PM - 5:00PM
- 0
Pneumonia is the most common cause of morbidity and mortality in children under 5 years old worldwide. Even though the developing world accounts for the vast majority of pediatric pneumonia-related mortality, pneumonia nevertheless has a considerable economic burden in wealthy nations due to high healthcare expenses. In this exercise, the multidisciplinary team's crucial role in the treatment of pediatric pneumonia is reviewed along with the cause, pathophysiology, and presentation of the condition.